We describe in three patients the use of adenosine to arrest the heart without cardiopulmonary bypass during endoluminal repair of thoracic aortic aneurysms. The pharmacology of adenosine, a purine nucleoside present in all cells, is reviewed briefly, with special reference to its use in causing transient asystole, which is required for successful surgical expansion of the graft stent in the thoracic aorta. (Br. J. Anaesth. 1997; 78: 444-448).
The advent of endoluminal grafting of the aorta 1 has required new approaches to the anaesthetic management of patients, particularly during balloon expansion of the aortic stent when arterial pressure must be reduced to prevent misplacement of the stent and damage to the proximal aorta or heart. We report three patients who received i.v. bolus doses of adenosine with the intention of causing asystole and hypotension at the time of expansion of the aortic stent of endoluminal grafts to the thoracic aorta.
Adenosine ("Adenocor" Sanofi Winthrop Pty Ltd), which is a relatively new antiarrhythmic agent for treating supraventricular tachycardia, is a naturally occurring purine nucleoside which transiently inhibits adenyl cyclase and 3, 5-cyclic adenosine monophosphate (cAMP) by binding to adenosine receptors, and has been shown to have major cardiovascular actions 2 3 (depression of sinoatrial (SA) and atrioventricular (AV) nodes; reduction in atrial contractility; attenuation of catecholamine effects primarily on the ventricles; depression of ventricular automaticity; and attenuation, via a presynaptic action, of adrenaline-induced noradrenaline release). The short duration of action, short half-life and effects on heart conduction make adenosine a useful drug in the diagnosis and management of supraventricular tachycardias such as Wolff-Parkinson-White syndrome. 4 5 Adenosine has also been useful in myocardial preservation during cardiac surgery because of cardiac arrest with a hyperpolarized myocardium rather than the more usual depolarized state, 6 although this has been challenged. , 2 days after operation). After premedication with papaveretum 15 mg and hyoscine 0.3 mg, anaesthesia consisted of tracheal intubation using thiopentone and tubocurarine block, and isoflurane and nitrous oxide in oxygen. Intra-arterial, pulmonary arterial, capillary wedge and central venous pressures were measured.
Surgical access was via surgical exposure of the left common iliac artery, and percutaneous cannulation of the right brachial artery. Adenosine was used at the time of balloon inflation to expand the stents in the descending thoracic aorta. Two grafts (White-Yu GAD 22 mm 7 mm) were used, one inside the distal part of the other (the so-called trombone technique). 8 With the patient heparinized, receiving 100% oxygen, and after a trial dose (of 12 mg) administered via the pulmonary artery catheter to determine the correct dose to stop the heart for the required time of 20-30 s, this dose of adenosine 12 mg was then used on two occasions at the time of balloon inflation of the stent grafts. Pulse oximetry demonstrated that 2 O p S always exceeded 99% at this time and her temperature was 34.5 ЊC from environmental cooling only. There were no adverse complications of the use of adenosine. In the early postoperative phase the patient developed a small left basal pleural effusion, and at 6 days after operation she required a right brachial artery thrombectomy (10 cm thrombus) which was related most probably to the brachial artery sheath used for surgical access in that arm. She was discharged 10 days after her original aortic operation. Six month surgical follow-up showed that the aneurysmal sac had been isolated. PATIENT , 4 days after operation). After premedication with papaveretum 15 mg and hyoscine 0.3 mg, anaesthesia consisted of placement of a thoracic extradural with the intention of using lignocaine to block the cardiac sympathetic nerves, tracheal intubation using thiopentone and tubocurarine/pancuronium block, and low-flow oxygen and nitrous oxide with isoflurane. Intraarterial, pulmonary arterial, capillary wedge and central venous pressures were measured.
Surgical access was via the right common femoral artery. Adenosine was used at the time of balloon inflation to expand the stents in the descending thoracic aorta. Two grafts were used, one inside the distal part of the other (White-Yu GAD 30 mm 12.5 mm). 8 With the patient heparinized, receiving 100% oxygen, and after trial doses of 9, 15, 24, 36 and 45 mg administered peripherally via an arm vein to determine the correct dose to stop the heart for the required time of 20-30 s, a dose of adenosine 45 mg was used on each occasion at the time of balloon inflation to expand the stent grafts. The patient's oxygen saturation was never less than 100% at this time and his temperature was 35.5 ЊC, again solely from environmental conditions. There were no adverse complications of the procedure. The patient was nursed initially in the ICU with IPPV overnight. The tracheal tube was removed on the first postoperative day and the patient transferred to the ward on the second day and discharged from hospital on the fifth postoperative day. Six month surgical follow-up showed that the aneurysmal sac had been isolated. PATIENT , 4 days after operation). After premedication with papaveretum 15 mg and hyoscine 0.3 mg, anaesthesia consisted of tracheal intubation using thiopentone and tubocurarine/pancuronium block and low flow oxygen and nitrous oxide with isoflurane. Intra-arterial, pulmonary arterial, capillary wedge and central venous pressures were measured.
Surgical access was via the left common femoral artery and right brachial artery. Adenosine was used at the time of balloon inflation to expand the stents in the descending thoracic aorta. Two grafts were used, one inside the distal part of the other (WhiteYu GAD 24 mm 15 mm and 24 mm 7 mm). 8 With the patient heparinized, receiving 100% oxygen, and after trial doses of 9 and 15 mg administered centrally via the pulmonary artery catheter to determine the correct dose to stop the heart for the required time of 20-30 s, a dose of adenosine 21 mg was used on the first occasion and 27 mg on the second occasion at the time of balloon inflation to expand the stent grafts. The patient's oxygen saturation was never less than 100% at this time and his temperature was 35.5 ЊC, again solely from environmental conditions. There were no adverse complications of the procedure. The patient was nursed initially in the ICU but his trachea was not intubated or his lungs ventilated. The patient was transferred to the ward the next day and discharged from hospital on the fifth postoperative day.
Discussion
Parodi, Palmaz and Barone 9 introduced endoluminal grafting of the aorta after animal experimentation by several groups, [10] [11] [12] [13] [14] and surgeons at our hospital have performed more than 150 abdominal aortic grafts. 15 Recently, repair of the thoracic aorta has also been performed by the endoluminal technique, 16 17 and this operation has required further evaluation of the place of hypotension at the time of expansion of the aortic stent to prevent both displacement of the stent and major damage to the aorta or undue strain on the myocardium leading to ischaemia or infarction. 18 19 If the stent is moved by the pressure of blood in the aorta forcing the inflating balloon distally at the time of expansion of the graft stent, there may be major problems in placement of the graft which is measured precisely before insertion. There may also be major problems, with aortic rupture or dissection, because of increased pressure in the aorta caused by balloon obstruction. The heart may also be stressed because of the increased demands on contractility and myocardial oxygen at the time of aortic obstruction by the balloon. 18 19 For endoluminal grafting of the abdominal aorta various anaesthetic hypotensive techniques, such as the use of sodium nitroprusside, glyceryl trinitrate, heavy volatile anaesthetic dose, and both lumbar and thoracic extradural block, have been used to reduce arterial pressure at the time of balloon inflation to expand the graft stent.
The work of Dorros and Cohn 20 during endoluminal grafting of the thoracic aorta suggested that adenosine would be an ideal agent to use to reduce arterial pressure by stopping the heart during surgical expansion of the proximal stent of the graft, which in these cases was to be by balloon inflation totally obstructing the thoracic aortic outflow. Adenosine occurs naturally in all cells, has no negative inotropic effects, has transient actions and decreases arterial pressure dramatically by causing asystole when given in high doses. 21 The pharmacology of adenosine is species specific but there appear to be two main adenosine receptors 21 22 -the A 1 receptor leading to inhibition of adenylate cyclase and thus decreased production of cAMP which is the dominant effect on cardiac electrophysiology 23 and the A 2 receptor leading to stimulation of adenylate cyclase and increased cAMP which is the dominant effect on vasodilatation. Recently in the rat there was a suggestion that there is a separate A 3 receptor mediating decreases in arterial pressure. 24 There are also effects on K ; channels in the heart inducing an outward potassium current and hyperpolarization of the cell membrane. 23 Hepatic and renal insufficiency do not affect duration of action, as adenosine is taken up and metabolized by red blood cells and vascular endothelium, with a half-life of approximately 2-10 s in low doses but increasing with higher doses to approximately 2 min. [25] [26] [27] Adenosine either enters the nucleotide pool by phosphorylation to AMP or is metabolized primarily to inosine, hypoxanthine, xanthine and ultimately uric acid. 22 Side effects of adenosine are transient SA node inactivity, atrial fibrillation, hypotension and flushing, and in the awake patient headache, transient chest pain and dyspnoea. 5 In larger doses adenosine produces suppression of SA node automaticity which is short lived. Adenosine should be used with caution in patients with bronchial asthma because inhaled adenosine has precipitated asthma, 28 and in patients with sick sinus syndrome or second-or third-degree heart block unless there is a pacemaker inserted. Patients receiving methylxanthines are resistant to adenosine because of competitive inhibition of A 1 and A 2 adenosine receptors, and patients receiving dipyridamole may have prolonged asystole with adenosine because of inhibition of the transport system into cells, with subsequent increases in adenosine concentrations. 22 29 Slow channel calcium blocking agents such as verapamil and nifedipine also inhibit the transport of adenosine into cells. 30 Benzodiazepines enhance the effects of adenosine 22 and carbamazepine is reported in the company's product information leaflet also to increase the degree of heart block.
Potentially, patients who have endoluminal repair of the thoracic aortic may need to have this procedure converted to open surgical repair if there is sudden rupture of the diseased aorta by intra-aortic surgical manipulations or if there are other surgical problems with placement of the endoluminal graft. Thus anaesthesia techniques need to take such possibilities into account when preparing the patient for surgery. This was the main reason why our second patient had a thoracic extradural inserted, although extradural block of the cardiac sympathetics was also planned to assist with myocardial, function, lower contractility and myocardial oxygen demand, and improve myocardial blood flow. 31 In addition, there may be a synergistic reduction in arterial pressure with administration of adenosine, which may prevent hypertension overcompensation on recovery from adenosine asystole.
Dorros and Cohn 20 recommended insertion of a temporary pacemaker before administration of adenosine. Our cardiological advice was that this was not necessary if an external pacing source was readily available, as it was most unlikely that the asystole would be prolonged in these patients who did not have any predisposing problems such as heart block or sick sinus syndrome.
The normal dose of adenosine for termination of supraventricular tachycardias is 3-6 mg and in some patients this dose has caused transient asystole. Larger doses cause some hypotension because of decreased peripheral vascular resistance even when asystole is not produced. The dose of adenosine to be used during expansion of the stent must be determined before the surgical manoeuvre, otherwise the duration of asystole and hence surgical time are unpredictable. Because the dose of adenosine required to produce asystole and the duration of asystole are unpredictable it is preferable to start with a dose of 9 mg, increasing in steps until asystole of the desired duration of approximately 20-30 s is produced. Our second patient proved relatively resistant requiring larger doses of adenosine than previously recommended, 20 but this may have been caused by administration of adenosine via a peripheral vein in this patient. Rankin and colleagues 32 showed that lower doses were needed (by a factor of one-third-3 mg vs 10 mg) when adenosine was administered centrally rather than peripherally, and we intend to give adenosine via a central vein in future. This patient was not receiving any drug therapy, such as methylxanthine, which has been reported to antagonize adenosine. 22 Another possible cause for the increased dose of adenosine in our second patient was the use of a thoracic extradural with full sympathetic block of the heart, as adenosine effects are reported to be more prominent when there is increased sympathetic tone. 33 There were no apparent cardiac, vascular or neurological sequelae to cessation of cardiac output for periods up to 45 s in our patients who were not specifically protected by hypothermic techniques throughout surgery, although mild hypothermia occurred in both patients, which may have had some protective effect on cerebral metabolism. 34 Life-threatening events after adenosine would appear to be rare 35 and although minor side effects are common in awake patients, most of these symptoms and signs are masked during anaesthesia. The major complications which are possible after this technique using adenosine would be fatal arrhythmias, thromboembolism, cerebral ischaemia or infarction, coronary ischaemia or infarction, stroke or paraplegia. All of these complications are possible with any surgical repair of thoracic aortic aneurysms, and we believe that in the endoluminal surgical repair they may be less likely or at least no more likely to occur than in standard open repair of the thoracic aorta with or without cardiopulmonary bypass. Caution in the use of adenosine in this way to cause asystole intentionally should be exercised in patients with cerebrovascular or cardiac ischaemia which could potentially be exacerbated by the period of hypotension and circulatory arrest, although adenosine has been used for both cerebral and coronary protection against ischaemic damage. 36 37 These contraindications should be borne in mind when surgeons are contemplating the use of adenosine in endoluminal thoracic aortic repair, as Dorros and Cohn 20 have recommended that adenosine should be used in all aortic repairs by the endoluminal technique, including abdominal. White, 38 in a commentary on their article, cautioned that such sweeping recommendations may be "detrimental to the wider application and appeal of the endoluminal technique". In any case it would appear to be unnecessary in endoluminal repair of the abdominal aorta. 1 8 15 We believe that the use of adenosine in considered cases of endoluminal repair of the thoracic aorta enhances the management of balloon inflation of the graft stent to allow better expansion to match the aortic diameter. This technique has the advantages of controlled transient hypotension with potential protection of the heart and brain.
